title: [Pharmacological differences between inhibitor drugs of the renin-angiotensin aldosterone system].
abstract: The activation of the renin-angiotensin-aldosterone cascade is a mechanism that generates high blood pressure. The structure has been identified and can be blocked through specific enzymatic pathways or receptors. We have a diversity of medications that act on this system. It is useful to develop the skill in clinical practice for selecting a drug from a wide variety. Renin-angiotensin system inhibitors share many pharmacological and pharmacokinetic characteristics but not all them are equivalent. Knowledge based on scientific evidence allows the clinician to choose the ideal drug for each patient.
authors.affiliation: Servicio de Nefrología, Hospital General Regional 25, Instituto Mexicano del Seguro Social, Distrito Federal, Mexico. amd740521@hotmail.com
authors.forename: Antonio
authors.initials: A
authors.lastname: Méndez-Durán
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000037:antagonists & inhibitors; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000809:Angiotensins / Q000037:antagonists & inhibitors*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000187:drug effects*; D000092502:Renin Inhibitors
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins; D000451:Mineralocorticoid Receptor Antagonists; D000092502:Renin Inhibitors